Loading...


 
 
     
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
 Click text to jump within video

NPS Pharmaceuticals CEO on Gattex's FDA Approval

Mon 07 Jan 13 | 06:15 PM ET
NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.

 
COMMENTS

ADD COMMENTS

Your Comments (Up to 1100 characters):
Remaining characters
1100
 
RELATED ARTICLES AND CONTENT
More Related Videos
Show
Cramer's Final Thoughts
Fri 17 May 13 | 06:59 PM ET
Company/Contributor
Companies That Shine After Spinoffs
Fri 17 May 13 | 06:29 PM ET
Company/Contributor
Mad Money, May 17, 2013
Fri 17 May 13 | 06:00 PM ET
Most Popular
Art Cashin: This Could Send Markets 'Parabolic'
Fri 17 May 13 | 11:45 AM ET
Displaying results for: Latest Video | US
Current DateTime: 08:54:11 27 Apr 2012 LinksList Documentid: 29778429
Current DateTime: 07:03:14 27 Apr 2012 LinksList Documentid: 29778428
Current DateTime: 08:01:38 27 Apr 2012 LinksList Documentid: 29779196
Current DateTime: 08:34:34 27 Apr 2012 LinksList Documentid: 29779197
Current DateTime: 08:34:34 27 Apr 2012 LinksList Documentid: This is New
Current DateTime: 01:32:38 26 Apr 2012 LinksList Documentid: 29779200
Current DateTime: 02:47:05 27 Apr 2012 LinksList Documentid: 29779199
CNBC CNBC
About CNBC  |  Site Map  |  Video Reprints  |  Advertise  |  Careers  |  Help  |  Contact
Privacy Policy  |  | Terms of Service  |  Independent Programming Report  |  Latest News Releases  |  RSS
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC. All Rights Reserved
A Division of NBCUniversal
Thomson Reuters Thomson Reuters